Tempest Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Tempest Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Tempest Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 26.6M shares, a 85.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26.6M +12.2M +85.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 24.5M +11.9M +94.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 22.2M +11.7M +110% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 22M +11.5M +110% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 14.3M +3.81M +36.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 12.6M +2.26M +21.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 10.6M +3.39M +47.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 10.5M +3.61M +52.2% Dec 31, 2022 10-K 2024-03-19
Q3 2022 10.5M +3.62M +52.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 10.3M +3.69M +55.6% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 7.17M -11.9M -62.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 6.91M +6.38M +1211% Dec 31, 2021 10-K 2023-03-22
Q3 2021 6.9M -12.1M -63.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 6.64M -12.4M -65.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 19M +44.8K +0.24% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 527K -17.7M -97.1% Dec 31, 2020 10-K 2022-03-29
Q3 2020 19M +5.53M +41% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 19M +5.59M +41.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 19M +5.64M +42.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 18.3M +4.91M +36.7% Dec 31, 2019 10-K 2021-03-29
Q3 2019 13.5M -22.4M -62.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 13.4M -22.4M -62.5% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 13.4M -22.4M -62.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 13.4M +13.1M +5322% Dec 31, 2018 10-K 2020-03-11
Q3 2018 35.8M +121K +0.34% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 35.8M +103K +0.29% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 35.8M +96.8K +0.27% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 246K -35.4M -99.3% Dec 31, 2017 10-K 2019-04-01
Q3 2017 35.7M +98.7K +0.28% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 35.7M +126K +0.36% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 35.7M +8.35M +30.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 35.6M +8.34M +30.6% Dec 31, 2016 10-K 2018-03-15
Q3 2016 35.6M +8.33M +30.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 35.6M +8.3M +30.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 27.3M +113K +0.42% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 27.3M +2.88M +11.8% Dec 31, 2015 10-K 2017-03-02
Q3 2015 27.3M +3M +12.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 27.3M +3.01M +12.4% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 27.2M +3.03M +12.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 24.4M +5.89M +31.8% Dec 31, 2014 10-K 2016-02-26
Q3 2014 24.3M +6.06M +33.2% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 24.3M +6.05M +33.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 24.2M +5.98M +32.9% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 18.5M +4.26M +29.9% Dec 31, 2013 10-K 2015-03-16
Q3 2013 18.2M +3.96M +27.8% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 18.2M +18.2M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 18.2M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 14.3M +10.7M +304% Dec 31, 2012 10-K 2014-02-27
Q3 2012 14.3M Sep 30, 2012 10-Q 2012-11-13
Q2 2012 3.53K* Jun 30, 2012 10-Q 2012-08-14
Q4 2011 3.53M Dec 31, 2011 10-K 2013-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.